SlideShare uma empresa Scribd logo
1 de 26
Baixar para ler offline
Investor Presentation
FY 2015/16
1
Contents
2
1 Hemas Business : Revenue and Profitability by Sector
2 History and Milestones
3 Consolidated Group Performance for FY 2015/16
4 Consumer
5 Healthcare
6 Transportation
7 Leisure
8 Sustainability
9 Vision 2020
Hemas is a Wellness, Leisure and Mobility
Business with LKR 38 billion in revenues
3
Revenue
Segmental Revenue and Operating Profits, FY 2015/16
Operating Profit (Rs. Mn) FY 2015/16
Consumer 1,768
Healthcare 1,780
Leisure 255
Transportation 499
Other (342)
Total 3,960
Consumer
38%
Healthcare
42%
Leisure
9%
Transportation
5%
Other
6%
-500
0
500
1000
1500
2000
Consumer Healthcare Leisure Transportation Other
OperatingProfitinLKRMillions
History and Milestones
4
201420132011
Entry into
Bangladesh
2007
Entered the
Hospital
business via
Acquisition
20031970s
Diversified into
travel &
tourism
1962
Entered the
Consumer
business
1948
Founded
Hemas
Drugs
Ltd.
Acquired J.L
Morison Son
& Jones
(Ceylon)
PLC
Exited
non-core
business
Hemas
Holdings
Listed on
CSE
Performance Indicator
(Rs. Mn)
FY
2015/16
FY
2014/15
% Change
Group Revenue 37,978 32,497 16.9%
Operating Profit 3,961 3,371 17.5%
Profit After Tax 2.926 2,196 33.2%
Group Earnings 2.653 1,927 37.7%
Performance Indicator
FY
2015/16
FY
2014/15
% Change
ROE 14.1% 12.9%
ROCE 16.8% 14.7%
EPS 4.63 3.74 23.9%
Net Assets per Share 38.41 30.39 26.3%
Share Price (Mar 31) 80.60 73.70 9.3%
Market Cap Rs. Mn (Mar 31) 46,147 37,977 21.5%
Consolidated revenues for FY 2015/16 was LKR 38 Bn, up
16.9% over the previous year, with Group Earnings up 37.7%
Growth coming primarily from strong performance in Consumer and Healthcare sectors.
Hemas Holdings PLC, FY 2015/16
• HHL recorded solid performance for FY 2015/16 with
consolidated Group of Rs. 38.0 Bn—a YoY growth of
16.9%.
• Operating profit reached Rs. 4.0 Bn and Earnings Rs.
2.7Bn, a growth of 17.5% and 37.7% respectively.
• Revenue growth was led by the strong performance of our
Consumer and Healthcare sectors and additional interest
income from the proceeds of the rights issue boosted
Earnings.
Segmental Earnings, FY 2015/16
5
-400
0
400
800
1,200
1,600
Consumer Healthcare Leisure Transportation Other
Rs. Millions
Consumer
6
Hemas Consumer is Sri Lanka’s largest domestic Personal
Care business, accounting for 38% of Group Revenues
Hair CareOral CareBaby Care
Feminine Hygiene Home CarePersonal Wash
7
Hemas entered Bangladesh in 2011, and today we are the
number two value-added hair oil brand with Kumarika
• Kumarika hair oil has 16% market share in the value added oil segment,
with 3-year revenue CAGR of 90%.
• 115,000 urban and rural retail outlets reached; distribution reach grown
15% annually.
• Operate own distribution, through a network of 140 distributors and over
100 sub-distributors.
• 280 sales reps operating in 21 territories.
• New product launched under “Kumarika” brand platform: two variants of
a science + nature face wash.
0
400
800
1,200
1,600
2,000
2010/11 2011/12 2012/13 2013/14 2014/15 2015/16
Bangladesh Revenue in Rs. Million
2010/11–2015/16
8
Market leader in personal care, strong iconic brands with
international relevance
Revenues up by 20% YoY, driven by robust volume growth in personal wash, feminine hygiene and home care.
• Portfolio comprises personal care, personal wash and
home care products.
• Market leader in baby care, hair oil, and beauty soap.
• Domestic distribution retail coverage of 80,000+.
• Introduced new Gel variants of Clogard along with
mouth wash product range and Velvet soap variants
“Water Lily & Sea Minerals”, “Honey and Yoghurt.”
• Fems, Clogard, Baby Cheramy and Diva brands
posted double digit topline growth rates underpinning
sector revenue growth.
Sector Highlights
• Consumer sector reported a total revenue of
Rs. 14.3Bn, a 20.2% YoY growth.
• Sector performance was driven by strong
performance of Bangladesh operation and sales
growth across all our major brands in the domestic
market, with relatively weak commodity prices for key
raw material inputs.
Financial Highlights
Consumer Revenue and Operating Profit
FY 2011/12–2015/16
Consumer Revenue Share, FY 2015/16
9
'-
350
700
1,050
1,400
1,750
2,100
'-
3,000
6,000
9,000
12,000
15,000
18,000
2011/12 2012/13 2013/14 2014/15 2015/16
OperatingProfit-Rs.Million
Revenue-Rs.Million
Revenue Operating Profit
Consumer
37.7%Rest of
Group
62.3%
Healthcare
10
Hemas is the largest healthcare company in Sri Lanka
with interests in Pharmaceuticals, Hospitals and Diagnostics
Pharmaceutical
Distribution
Rx &
OTC
Pharmaceutical
Manufacturing
Hospitals &
Diagnostics
Network
11
In pharmaceutical distribution, Hemas represents the largest
global multinational pharmaceutical manufacturers
650
Employees
35+
Principals
9
Therapeutic
Categories
22%
Market Share 3000+
Pharmacies
12
Hemas
Pharmaceuticals
OTC Own Brands
• Lacto Calamine
• Gripe Mixture
• Baby Cough Syrup
• Valmelix Cough Syrup
JLM, acquired in 2013, is a market leading Rx manufacturer
with leading OTC brands
J.L. Morison Son & Jones
33%
Earnings
CAGR since
acquisition
Rs. 000’ FY 2014 FY 2015 FY 2016
Revenue 2,638,931 3,025,969 3,714,848
Operating Profit 258,189 324,173 460,516
Earnings 210,757 247,091 351,179
Financial Highlights
13
• Manufactures over sixty formulations of high quality
pharmaceutical and OTC products.
• Import and distribution of internationally renowned products via
our island-wide distribution network.
• JLM signed a five year buy-back agreement with the Government
of Sri Lanka to provide essential medicines to the National
Healthcare system.
• JLM revenue and earnings for the year grew by 22.8% and
43.4% respectively supported by the growth of core segments,
improved efficiency and capacity gains at plant, and the strength
of a newly restructured distribution network.
Hemas is the first hospital chain to take high quality private
healthcare to rapidly growing Colombo suburbs
• 3 multi-specialty, ACHSI accredited hospitals built on international
standards in the North of Colombo, East of Colombo and in the
Southern Province.
• 3 additional laboratories opened this year; bring network up to 36
laboratories, serving over 500 physicians and addressing a patient
population of 5 million.
• Through our new corporate polyclinic model, we are locating in
large working population environments, with a continued focus on
bringing healthcare to the consumer.
14
Wattala 100 beds Thalawathugoda 60 beds Galle 50 beds
Healthcare
42.5%Rest of Group
57.5%
Deep experience across healthcare value chain with market
leading positions in distribution and diagnostics
Sector Highlights
Financial Highlights
• Healthcare segment of the Group achieved sales of
Rs.16.1Bn, a growth of 16.0%.
• 8% growth in Pharma distribution revenues indicates
encouraging performance, during a period of significant
regulatory change in the pharmaceutical industry.
• Increased demand for private healthcare and health
seeking behavior growing demand for diagnostics, all
three hospitals recorded a revenue growth of 31.9% YoY.
Healthcare Revenue and Operating Profit
FY 2011/12–2015/16
Healthcare Revenue Share, FY 2015/16
15
'-
325
650
975
1,300
1,625
1,950
'-
3,000
6,000
9,000
12,000
15,000
18,000
2011/12 2012/13 2013/14 2014/15 2015/16
OperatingProfit-Rs.Million
Revenue-Rs.Million
Revenue Operating Profit
• Hemas Hospitals opened its first wellness centre to
6,000 plus employees at Colombo’s premier IT park,
Orion City.
• Wattala and Southern Hospitals were re-accredited by
the ACHSI and Hemas Hospital Thalawathugoda
obtained its 1st accreditation during the year.
• Pharmaceutical business grew Rx and OTC portfolio
consistently, adding new principles.
• JLM’s buyback agreement and continued focus on
distribution efficiency contributed to the growth in sales
Transportation
16
Travel and
Aviation
OutboundMaritimeLogistics
• Hemas offers complete passenger
and cargo solutions in Airline
Representation and travel related
services
• Hemas represents airlines
Emirates, Malaysia Airline and
Maldivian and other major airlines.
• Largest GSA operator in passenger
and cargo with a market share of
25% and 20%, respectively
• Grew Emirates airlines from 1 flight
per day to 7 flights per day
• 5th in the travel market
• Integrated portfolio of
container haulage, container
yard operations, warehousing,
automotive logistics and
transportation of project and
over-dimensional cargo.
• 6 acre container terminal.
• Maritime sector acts as a
shipping agent providing
agency services for our feeder
operator.
• Far Shipping Lines (FSL)
Singapore
• Operates the largest feeder
service to the Bay of Bengal
• Exclusive agent for ‘HC line’
and NVOCC operator ‘Asian
Tiger Shipping’
• Appointed General Agents for
Evergreen, the fourth largest
mainliner with revenues of
US$ 4 Bn.
• Award winning, IATA
accredited travel agency.
• Corporate travel service is a
network partner of HRG which
offers global travel services
and hotel reservations.
17
Through our Mobility arm, we are securing new accounts and
growing capacity in logistics, warehousing and haulage
Transportation
4.7%
Rest of Group
95.3%
Our Mobility business had LKR 1.8 billion in revenues for FY
2015/16, a year-on-year growth of 17%
Sector Highlights
Financial Highlights
• Transportation sector revenue of Rs.1.8 Bn reflects a
YoY growth of 17.2%, stemming from strong
performance of our domestic maritime and logistics
business interests.
• Logistics business grew through new projects, with our
warehouses operating with full capacity and haulage
business growing with the car carrier operation.
• Aviation businesses continued to experience challenges
due to lower yields of ticketing income.
• Operating profits grew at a slower rate of 8.2% when
compared to the revenue growth rate, due to limited
growth reflected in aviation.
Transportation Revenue and Operating Profit
FY 2011/12–2015/16
Transportation Revenue Share, FY 2015/16
18
'-
85
170
255
340
425
510
595
'-
325
650
975
1,300
1,625
1,950
2011/12 2012/13 2013/14 2014/15 2015/16
OperatingProfit-Rs.Million
Revenue-Rs.Million
Revenue Operating Profit
• Hemas Maritime appointed General Agents for
Evergreen Marine Corporation Taiwan, one of the
largest feeder carriers servicing the Port of Colombo.
• Strategic investments in logistics verticals providing
integrated end to end solutions
• Good growth in Logistics 3PL business with increased
volumes stemming from the container depot which
functioned at its optimum level of efficiency.
Leisure
19
Our Leisure business comprises leading travel brands and an
inbound leisure business
• Serendib Leisure Group of Hotels which, includes four award winning
properties with a total inventory of 550 rooms.
• The partnership with Minor Hotel Group (MHG) has enabled Serendib Leisure
to be the only Sri Lankan hotel chain to manage an international brand,
“AVANI”.
Coming Soon
20
Leisure
9.0%
Rest of Group
91.0%
We are investing in Sri Lanka’s tourism boom with a selection of
new builds, targeting the upper star class segment of the market
YTD revenues of LKR 3.4Bn, with 13.0% increase year on year.
• Owner and Manager of ffive properties with a combined
room inventory of 563.
• Strategic partnership with Minor Hotel Group, a leading
Asian hotel chain
• During December 2016, we opened our newest hotel
property, Anantara Peace Haven Tangalle Resort, this
property will establish a new benchmark for luxury
travellers to Sri Lanka seeking authentic cultural
experiences.
• The hotels group revenue grew by 12.2% owing to the
strong performance of AVANI Bentota and Hotel Sigiriya
• Diethelm Travels recorded a 21% growth in the inbound
volume which resulted a 14% growth in the topline.
Sector Highlights
Financial Highlights
• Leisure segment recorded a total revenue of Rs. 3.4Bn
for FY 2015/16, registering a 13.0% YoY increase.
• The increase was primarily driven by a good overall
occupancy rate of 79%.
• The first few months of the new hotel Anantara Tangalle
has been encouraging.
Leisure Revenue and Operating Profit
FY 2011/12–2015/16
Leisure Revenue Share, FY 2015/16
21
'-
65
130
195
260
325
390
455
520
585
'-
550
1,100
1,650
2,200
2,750
3,300
3,850
2011/12 2012/13 2013/14 2014/15 2015/16
OperatingProfit-Rs.Million
Revenue-Rs.Million
Revenue Operating Profit
Sustainability
22
Enriching lives through the spirit of Abhimana
• Abhimana’ is our ethos of sustainability that
describes our vision of a sustainable and co-
operative society, of people living and working
together
• Inline with this, we have released our Sustainability
Report providing insight into the Group’s
sustainability philosophy and initiatives in line with
the Global Reporting Initiative G4 guidelines (GRI-
G4) : http://www.hemas.com/reports
• Today, our strategic path is governed not only by
how well we develop growing commercial
opportunities but also by listening to and
responding to the communities of which we are a
part.
23
Piyawara
• The Hemas ‘Piyawara’ project focuses on early
childhood care and development, penetrating the
segment by facilitating preschool education for
children aged 3 to 5 years, from marginalised
communities.
• With the mission “to nurture young children with
good care in order to provide a solid foundation of
a life long journey”
24
Vision 2020 - To be the best at enriching lives
• Delighting South Asian consumers with our high quality innovative personal care
solutions
• Providing excellent healthcare outcomes for all Sri Lankans
• Outstanding leisure experiences to the emerging traveler
• Driving exceptional mobility solutions for the travel and logistics needs of the nation
• While at all times operating true to Hemas Values and our ethos of Abhimana
25
2020
Vision
Thank You
CONFIDENTIALITY AGREEMENT:
Any confidential information discussed in this presentation shall be used by the receiving party exclusively for the purposes
of fulfilling the receiving party’s obligation and for no other purpose except with the consent of the disclosing party.
Hemas Investor Relations:
Telephone: +94 11 4 731 731 (Ext. 1278)
Email: ir@hemas.com
Web: http://www.hemas.com
Hemas Holdings PLC
Hemas House, 75, Braybrooke Place,
Colombo 2, Sri Lanka
26

Mais conteúdo relacionado

Mais procurados

SWOT Analysis - Hemas holdings PLC Sri Lanka
SWOT Analysis - Hemas holdings PLC Sri Lanka SWOT Analysis - Hemas holdings PLC Sri Lanka
SWOT Analysis - Hemas holdings PLC Sri Lanka mnikzaad
 
Recruitment and Selection Process-Unilever
Recruitment and Selection Process-UnileverRecruitment and Selection Process-Unilever
Recruitment and Selection Process-UnileverFahim Hasanul Islam
 
Business and Business Environment - TASK 01 & TASK 02
Business and Business Environment - TASK 01 & TASK 02Business and Business Environment - TASK 01 & TASK 02
Business and Business Environment - TASK 01 & TASK 02Akshana Sivakumar
 
Porters five forces model on fmcg
Porters five forces model on fmcgPorters five forces model on fmcg
Porters five forces model on fmcgRameez Ahmed
 
Strategic analysis of etisalat
Strategic analysis of etisalatStrategic analysis of etisalat
Strategic analysis of etisalatparitosh kashyap
 
Telecommunication industry in Sri Lanka (Group presentation ) 2016
Telecommunication industry in Sri Lanka (Group presentation ) 2016Telecommunication industry in Sri Lanka (Group presentation ) 2016
Telecommunication industry in Sri Lanka (Group presentation ) 2016Nirasha Nissanka
 
HUL Distribution Model
HUL Distribution ModelHUL Distribution Model
HUL Distribution ModelAnurag Gupta
 
Presentation1 (1)
Presentation1 (1)Presentation1 (1)
Presentation1 (1)Rameez Riaz
 
CSR practise of Pran-RFL Group
CSR practise of Pran-RFL GroupCSR practise of Pran-RFL Group
CSR practise of Pran-RFL GroupAtiqur Rahman
 
Situational analysis & integrated communication plan for Keells Super.
Situational analysis & integrated communication plan for Keells Super.Situational analysis & integrated communication plan for Keells Super.
Situational analysis & integrated communication plan for Keells Super.Dayenkie Chandrasekera
 
PESTAL Analysis of LG Electronics
 PESTAL Analysis of LG Electronics PESTAL Analysis of LG Electronics
PESTAL Analysis of LG ElectronicsDheerajRajpurohit2
 
Tata motors - Consumer Buyer Behavior
Tata motors - Consumer Buyer BehaviorTata motors - Consumer Buyer Behavior
Tata motors - Consumer Buyer BehaviorDhananjay Mull
 
Distribution Channel In FMCG
Distribution Channel In FMCGDistribution Channel In FMCG
Distribution Channel In FMCGAnant Sirohi
 
Presentation ptcl
Presentation ptclPresentation ptcl
Presentation ptclA.W.Paracha
 

Mais procurados (20)

SWOT Analysis - Hemas holdings PLC Sri Lanka
SWOT Analysis - Hemas holdings PLC Sri Lanka SWOT Analysis - Hemas holdings PLC Sri Lanka
SWOT Analysis - Hemas holdings PLC Sri Lanka
 
Recruitment and Selection Process-Unilever
Recruitment and Selection Process-UnileverRecruitment and Selection Process-Unilever
Recruitment and Selection Process-Unilever
 
Marico
MaricoMarico
Marico
 
It industry swot analysis
It industry swot analysisIt industry swot analysis
It industry swot analysis
 
Business and Business Environment - TASK 01 & TASK 02
Business and Business Environment - TASK 01 & TASK 02Business and Business Environment - TASK 01 & TASK 02
Business and Business Environment - TASK 01 & TASK 02
 
Porters five forces model on fmcg
Porters five forces model on fmcgPorters five forces model on fmcg
Porters five forces model on fmcg
 
Strategic analysis of etisalat
Strategic analysis of etisalatStrategic analysis of etisalat
Strategic analysis of etisalat
 
Telecommunication industry in Sri Lanka (Group presentation ) 2016
Telecommunication industry in Sri Lanka (Group presentation ) 2016Telecommunication industry in Sri Lanka (Group presentation ) 2016
Telecommunication industry in Sri Lanka (Group presentation ) 2016
 
HUL Distribution Model
HUL Distribution ModelHUL Distribution Model
HUL Distribution Model
 
Presentation1 (1)
Presentation1 (1)Presentation1 (1)
Presentation1 (1)
 
CSR practise of Pran-RFL Group
CSR practise of Pran-RFL GroupCSR practise of Pran-RFL Group
CSR practise of Pran-RFL Group
 
Situational analysis & integrated communication plan for Keells Super.
Situational analysis & integrated communication plan for Keells Super.Situational analysis & integrated communication plan for Keells Super.
Situational analysis & integrated communication plan for Keells Super.
 
PESTAL Analysis of LG Electronics
 PESTAL Analysis of LG Electronics PESTAL Analysis of LG Electronics
PESTAL Analysis of LG Electronics
 
Assignment - Maliban
Assignment - MalibanAssignment - Maliban
Assignment - Maliban
 
Tata motors - Consumer Buyer Behavior
Tata motors - Consumer Buyer BehaviorTata motors - Consumer Buyer Behavior
Tata motors - Consumer Buyer Behavior
 
Tcs
Tcs  Tcs
Tcs
 
Accounting assignment#01
Accounting assignment#01Accounting assignment#01
Accounting assignment#01
 
Distribution Channel In FMCG
Distribution Channel In FMCGDistribution Channel In FMCG
Distribution Channel In FMCG
 
Hassaan Assignment
Hassaan AssignmentHassaan Assignment
Hassaan Assignment
 
Presentation ptcl
Presentation ptclPresentation ptcl
Presentation ptcl
 

Destaque

Hemas investor presentation june 2011
Hemas investor presentation june 2011Hemas investor presentation june 2011
Hemas investor presentation june 2011HEMAS HOLDINGS PLC
 
Hemas Holdings PLC investor presentation - Q1 2016/17
Hemas Holdings PLC investor presentation - Q1 2016/17Hemas Holdings PLC investor presentation - Q1 2016/17
Hemas Holdings PLC investor presentation - Q1 2016/17HEMAS HOLDINGS PLC
 
Hemas Investor Presentation 2012/13
Hemas Investor Presentation 2012/13Hemas Investor Presentation 2012/13
Hemas Investor Presentation 2012/13HEMAS HOLDINGS PLC
 
Investor presentation 1H 2012/13
Investor presentation 1H 2012/13Investor presentation 1H 2012/13
Investor presentation 1H 2012/13HEMAS HOLDINGS PLC
 
Hemas Holdings PLC Investor Presentation Q3 2016-17
Hemas Holdings PLC Investor Presentation Q3 2016-17Hemas Holdings PLC Investor Presentation Q3 2016-17
Hemas Holdings PLC Investor Presentation Q3 2016-17HEMAS HOLDINGS PLC
 
Hemas Holdings PLC Investor Presentation Q3, 2013/14
Hemas Holdings PLC Investor Presentation Q3, 2013/14Hemas Holdings PLC Investor Presentation Q3, 2013/14
Hemas Holdings PLC Investor Presentation Q3, 2013/14HEMAS HOLDINGS PLC
 
Investor Presentation Q3 2012/13
Investor Presentation Q3 2012/13Investor Presentation Q3 2012/13
Investor Presentation Q3 2012/13HEMAS HOLDINGS PLC
 
Hemas Holdings PLC investor presentation - Q2 2016/17
Hemas Holdings PLC investor presentation - Q2 2016/17Hemas Holdings PLC investor presentation - Q2 2016/17
Hemas Holdings PLC investor presentation - Q2 2016/17HEMAS HOLDINGS PLC
 
Hemas Holdings PLC Investor Presentation Q1 2017/18
Hemas Holdings PLC Investor Presentation Q1 2017/18 Hemas Holdings PLC Investor Presentation Q1 2017/18
Hemas Holdings PLC Investor Presentation Q1 2017/18 HEMAS HOLDINGS PLC
 
Hemas Holdings PLC - Investor Presentation Q1 2013/14
Hemas Holdings PLC - Investor Presentation Q1 2013/14Hemas Holdings PLC - Investor Presentation Q1 2013/14
Hemas Holdings PLC - Investor Presentation Q1 2013/14HEMAS HOLDINGS PLC
 
Hemas Holdings Investor Presentation 1H 2013/14
Hemas Holdings Investor Presentation 1H 2013/14Hemas Holdings Investor Presentation 1H 2013/14
Hemas Holdings Investor Presentation 1H 2013/14HEMAS HOLDINGS PLC
 

Destaque (11)

Hemas investor presentation june 2011
Hemas investor presentation june 2011Hemas investor presentation june 2011
Hemas investor presentation june 2011
 
Hemas Holdings PLC investor presentation - Q1 2016/17
Hemas Holdings PLC investor presentation - Q1 2016/17Hemas Holdings PLC investor presentation - Q1 2016/17
Hemas Holdings PLC investor presentation - Q1 2016/17
 
Hemas Investor Presentation 2012/13
Hemas Investor Presentation 2012/13Hemas Investor Presentation 2012/13
Hemas Investor Presentation 2012/13
 
Investor presentation 1H 2012/13
Investor presentation 1H 2012/13Investor presentation 1H 2012/13
Investor presentation 1H 2012/13
 
Hemas Holdings PLC Investor Presentation Q3 2016-17
Hemas Holdings PLC Investor Presentation Q3 2016-17Hemas Holdings PLC Investor Presentation Q3 2016-17
Hemas Holdings PLC Investor Presentation Q3 2016-17
 
Hemas Holdings PLC Investor Presentation Q3, 2013/14
Hemas Holdings PLC Investor Presentation Q3, 2013/14Hemas Holdings PLC Investor Presentation Q3, 2013/14
Hemas Holdings PLC Investor Presentation Q3, 2013/14
 
Investor Presentation Q3 2012/13
Investor Presentation Q3 2012/13Investor Presentation Q3 2012/13
Investor Presentation Q3 2012/13
 
Hemas Holdings PLC investor presentation - Q2 2016/17
Hemas Holdings PLC investor presentation - Q2 2016/17Hemas Holdings PLC investor presentation - Q2 2016/17
Hemas Holdings PLC investor presentation - Q2 2016/17
 
Hemas Holdings PLC Investor Presentation Q1 2017/18
Hemas Holdings PLC Investor Presentation Q1 2017/18 Hemas Holdings PLC Investor Presentation Q1 2017/18
Hemas Holdings PLC Investor Presentation Q1 2017/18
 
Hemas Holdings PLC - Investor Presentation Q1 2013/14
Hemas Holdings PLC - Investor Presentation Q1 2013/14Hemas Holdings PLC - Investor Presentation Q1 2013/14
Hemas Holdings PLC - Investor Presentation Q1 2013/14
 
Hemas Holdings Investor Presentation 1H 2013/14
Hemas Holdings Investor Presentation 1H 2013/14Hemas Holdings Investor Presentation 1H 2013/14
Hemas Holdings Investor Presentation 1H 2013/14
 

Semelhante a Hemas Holdings PLC investor presentation 2015/16

Hemas Holdings PLC Investor Presentation Q3 - 2015/16
 Hemas Holdings PLC Investor Presentation Q3 - 2015/16 Hemas Holdings PLC Investor Presentation Q3 - 2015/16
Hemas Holdings PLC Investor Presentation Q3 - 2015/16HEMAS HOLDINGS PLC
 
Hemas Holdings PLC Investor Presentation Q4 2017/18
Hemas Holdings PLC Investor Presentation Q4 2017/18Hemas Holdings PLC Investor Presentation Q4 2017/18
Hemas Holdings PLC Investor Presentation Q4 2017/18HEMAS HOLDINGS PLC
 
Proposal for Medical Supplies
Proposal for Medical SuppliesProposal for Medical Supplies
Proposal for Medical SuppliesAbbas Ahmed
 
Apresentação Institucional - Hypermarcas
Apresentação Institucional - HypermarcasApresentação Institucional - Hypermarcas
Apresentação Institucional - HypermarcasHypermarcasRi
 
Tech emerge webinar2 planning
Tech emerge webinar2 planningTech emerge webinar2 planning
Tech emerge webinar2 planninghealth2dev
 
Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Alkesh Parihar
 
Ppt inst short 2806 eng
Ppt inst short 2806 engPpt inst short 2806 eng
Ppt inst short 2806 engHypermarcasRi
 
IMS Report - Gaspare Mura
IMS Report - Gaspare MuraIMS Report - Gaspare Mura
IMS Report - Gaspare MuraGaspare Mura
 
Profarma healthcare15 vf_2
Profarma healthcare15 vf_2Profarma healthcare15 vf_2
Profarma healthcare15 vf_2Profarma
 
Rollins 2011 ar
Rollins 2011 arRollins 2011 ar
Rollins 2011 aramy_ostler
 
Presentation on Colgate Toothpaste
Presentation on Colgate ToothpastePresentation on Colgate Toothpaste
Presentation on Colgate ToothpasteVipul Mittal
 
Alkem IPO Page-Dec 15
Alkem IPO Page-Dec 15Alkem IPO Page-Dec 15
Alkem IPO Page-Dec 15Gaurav Singh
 
Dr. morepen sushil suri
Dr. morepen sushil suriDr. morepen sushil suri
Dr. morepen sushil surimorepen
 
MicroCapClub Invitational: FitLife Brands (FTLF)
MicroCapClub Invitational: FitLife Brands (FTLF)MicroCapClub Invitational: FitLife Brands (FTLF)
MicroCapClub Invitational: FitLife Brands (FTLF)Ian Cassel
 
All-New Investor Presentation - Motilal Oswal Financial Services India Profile
All-New Investor Presentation - Motilal Oswal Financial Services India ProfileAll-New Investor Presentation - Motilal Oswal Financial Services India Profile
All-New Investor Presentation - Motilal Oswal Financial Services India ProfileSouth Asia Fast Track
 
Return plus january 2015
Return plus january 2015Return plus january 2015
Return plus january 2015Arpita0306
 
Merger of HUL and GSK CH India - HUL Presentation.pdf
Merger of HUL and GSK CH India - HUL Presentation.pdfMerger of HUL and GSK CH India - HUL Presentation.pdf
Merger of HUL and GSK CH India - HUL Presentation.pdfpgba22pulkitg
 

Semelhante a Hemas Holdings PLC investor presentation 2015/16 (20)

Hemas Holdings PLC Investor Presentation Q3 - 2015/16
 Hemas Holdings PLC Investor Presentation Q3 - 2015/16 Hemas Holdings PLC Investor Presentation Q3 - 2015/16
Hemas Holdings PLC Investor Presentation Q3 - 2015/16
 
Hemas Holdings PLC Investor Presentation Q4 2017/18
Hemas Holdings PLC Investor Presentation Q4 2017/18Hemas Holdings PLC Investor Presentation Q4 2017/18
Hemas Holdings PLC Investor Presentation Q4 2017/18
 
Proposal for Medical Supplies
Proposal for Medical SuppliesProposal for Medical Supplies
Proposal for Medical Supplies
 
Apresentação Institucional - Hypermarcas
Apresentação Institucional - HypermarcasApresentação Institucional - Hypermarcas
Apresentação Institucional - Hypermarcas
 
Tech emerge webinar2 planning
Tech emerge webinar2 planningTech emerge webinar2 planning
Tech emerge webinar2 planning
 
Valeant Investor Day 2015 Presentation
Valeant Investor Day 2015 PresentationValeant Investor Day 2015 Presentation
Valeant Investor Day 2015 Presentation
 
Vim
VimVim
Vim
 
Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)
 
Ppt inst short 2806 eng
Ppt inst short 2806 engPpt inst short 2806 eng
Ppt inst short 2806 eng
 
IMS Report - Gaspare Mura
IMS Report - Gaspare MuraIMS Report - Gaspare Mura
IMS Report - Gaspare Mura
 
Profarma healthcare15 vf_2
Profarma healthcare15 vf_2Profarma healthcare15 vf_2
Profarma healthcare15 vf_2
 
Rollins 2011 ar
Rollins 2011 arRollins 2011 ar
Rollins 2011 ar
 
Presentation on Colgate Toothpaste
Presentation on Colgate ToothpastePresentation on Colgate Toothpaste
Presentation on Colgate Toothpaste
 
Hikma pharmaceuticals PLC
Hikma pharmaceuticals PLCHikma pharmaceuticals PLC
Hikma pharmaceuticals PLC
 
Alkem IPO Page-Dec 15
Alkem IPO Page-Dec 15Alkem IPO Page-Dec 15
Alkem IPO Page-Dec 15
 
Dr. morepen sushil suri
Dr. morepen sushil suriDr. morepen sushil suri
Dr. morepen sushil suri
 
MicroCapClub Invitational: FitLife Brands (FTLF)
MicroCapClub Invitational: FitLife Brands (FTLF)MicroCapClub Invitational: FitLife Brands (FTLF)
MicroCapClub Invitational: FitLife Brands (FTLF)
 
All-New Investor Presentation - Motilal Oswal Financial Services India Profile
All-New Investor Presentation - Motilal Oswal Financial Services India ProfileAll-New Investor Presentation - Motilal Oswal Financial Services India Profile
All-New Investor Presentation - Motilal Oswal Financial Services India Profile
 
Return plus january 2015
Return plus january 2015Return plus january 2015
Return plus january 2015
 
Merger of HUL and GSK CH India - HUL Presentation.pdf
Merger of HUL and GSK CH India - HUL Presentation.pdfMerger of HUL and GSK CH India - HUL Presentation.pdf
Merger of HUL and GSK CH India - HUL Presentation.pdf
 

Último

VIP 7001035870 Find & Meet Hyderabad Call Girls Abids high-profile Call Girl
VIP 7001035870 Find & Meet Hyderabad Call Girls Abids high-profile Call GirlVIP 7001035870 Find & Meet Hyderabad Call Girls Abids high-profile Call Girl
VIP 7001035870 Find & Meet Hyderabad Call Girls Abids high-profile Call Girladitipandeya
 
Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024CollectiveMining1
 
Call Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service Available
Call Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service AvailableCall Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service Available
Call Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service AvailableSheetaleventcompany
 
Q3 FY24 Earnings Conference Call Presentation
Q3 FY24 Earnings Conference Call PresentationQ3 FY24 Earnings Conference Call Presentation
Q3 FY24 Earnings Conference Call PresentationSysco_Investors
 
Editing progress 20th march.docxxxxxxxxx
Editing progress 20th march.docxxxxxxxxxEditing progress 20th march.docxxxxxxxxx
Editing progress 20th march.docxxxxxxxxxMollyBrown86
 
VVIP Pune Call Girls Sopan Baug WhatSapp Number 8005736733 With Elite Staff A...
VVIP Pune Call Girls Sopan Baug WhatSapp Number 8005736733 With Elite Staff A...VVIP Pune Call Girls Sopan Baug WhatSapp Number 8005736733 With Elite Staff A...
VVIP Pune Call Girls Sopan Baug WhatSapp Number 8005736733 With Elite Staff A...SUHANI PANDEY
 
Teck Investor Presentation, April 24, 2024
Teck Investor Presentation, April 24, 2024Teck Investor Presentation, April 24, 2024
Teck Investor Presentation, April 24, 2024TeckResourcesLtd
 
VIP Call Girl Amritsar 7001035870 Enjoy Call Girls With Our Escorts
VIP Call Girl Amritsar 7001035870 Enjoy Call Girls With Our EscortsVIP Call Girl Amritsar 7001035870 Enjoy Call Girls With Our Escorts
VIP Call Girl Amritsar 7001035870 Enjoy Call Girls With Our Escortssonatiwari757
 
Ambala Escorts Service ☎️ 6378878445 ( Sakshi Sinha ) High Profile Call Girls...
Ambala Escorts Service ☎️ 6378878445 ( Sakshi Sinha ) High Profile Call Girls...Ambala Escorts Service ☎️ 6378878445 ( Sakshi Sinha ) High Profile Call Girls...
Ambala Escorts Service ☎️ 6378878445 ( Sakshi Sinha ) High Profile Call Girls...mriyagarg453
 
slideshare Call girls Noida Escorts 9999965857 henakhan
slideshare Call girls Noida Escorts 9999965857 henakhanslideshare Call girls Noida Escorts 9999965857 henakhan
slideshare Call girls Noida Escorts 9999965857 henakhanhanshkumar9870
 
B2 Interpret the brief.docxccccccccccccccc
B2 Interpret the brief.docxcccccccccccccccB2 Interpret the brief.docxccccccccccccccc
B2 Interpret the brief.docxcccccccccccccccMollyBrown86
 
Enjoy Night⚡Call Girls Udyog Vihar Gurgaon >༒8448380779 Escort Service
Enjoy Night⚡Call Girls Udyog Vihar Gurgaon >༒8448380779 Escort ServiceEnjoy Night⚡Call Girls Udyog Vihar Gurgaon >༒8448380779 Escort Service
Enjoy Night⚡Call Girls Udyog Vihar Gurgaon >༒8448380779 Escort ServiceDelhi Call girls
 
Nicola Mining Inc. Corporate Presentation May 2024
Nicola Mining Inc. Corporate Presentation May 2024Nicola Mining Inc. Corporate Presentation May 2024
Nicola Mining Inc. Corporate Presentation May 2024nicola_mining
 

Último (20)

VIP 7001035870 Find & Meet Hyderabad Call Girls Abids high-profile Call Girl
VIP 7001035870 Find & Meet Hyderabad Call Girls Abids high-profile Call GirlVIP 7001035870 Find & Meet Hyderabad Call Girls Abids high-profile Call Girl
VIP 7001035870 Find & Meet Hyderabad Call Girls Abids high-profile Call Girl
 
Rohini Sector 15 Call Girls Delhi 9999965857 @Sabina Saikh No Advance
Rohini Sector 15 Call Girls Delhi 9999965857 @Sabina Saikh No AdvanceRohini Sector 15 Call Girls Delhi 9999965857 @Sabina Saikh No Advance
Rohini Sector 15 Call Girls Delhi 9999965857 @Sabina Saikh No Advance
 
Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024
 
Call Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service Available
Call Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service AvailableCall Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service Available
Call Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service Available
 
Vip Call Girls South Ex ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Vip Call Girls South Ex ➡️ Delhi ➡️ 9999965857 No Advance 24HRS LiveVip Call Girls South Ex ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Vip Call Girls South Ex ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
 
@9999965857 🫦 Sexy Desi Call Girls Karol Bagh 💓 High Profile Escorts Delhi 🫶
@9999965857 🫦 Sexy Desi Call Girls Karol Bagh 💓 High Profile Escorts Delhi 🫶@9999965857 🫦 Sexy Desi Call Girls Karol Bagh 💓 High Profile Escorts Delhi 🫶
@9999965857 🫦 Sexy Desi Call Girls Karol Bagh 💓 High Profile Escorts Delhi 🫶
 
Q3 FY24 Earnings Conference Call Presentation
Q3 FY24 Earnings Conference Call PresentationQ3 FY24 Earnings Conference Call Presentation
Q3 FY24 Earnings Conference Call Presentation
 
Editing progress 20th march.docxxxxxxxxx
Editing progress 20th march.docxxxxxxxxxEditing progress 20th march.docxxxxxxxxx
Editing progress 20th march.docxxxxxxxxx
 
VVIP Pune Call Girls Sopan Baug WhatSapp Number 8005736733 With Elite Staff A...
VVIP Pune Call Girls Sopan Baug WhatSapp Number 8005736733 With Elite Staff A...VVIP Pune Call Girls Sopan Baug WhatSapp Number 8005736733 With Elite Staff A...
VVIP Pune Call Girls Sopan Baug WhatSapp Number 8005736733 With Elite Staff A...
 
Teck Investor Presentation, April 24, 2024
Teck Investor Presentation, April 24, 2024Teck Investor Presentation, April 24, 2024
Teck Investor Presentation, April 24, 2024
 
VIP Call Girl Amritsar 7001035870 Enjoy Call Girls With Our Escorts
VIP Call Girl Amritsar 7001035870 Enjoy Call Girls With Our EscortsVIP Call Girl Amritsar 7001035870 Enjoy Call Girls With Our Escorts
VIP Call Girl Amritsar 7001035870 Enjoy Call Girls With Our Escorts
 
Ambala Escorts Service ☎️ 6378878445 ( Sakshi Sinha ) High Profile Call Girls...
Ambala Escorts Service ☎️ 6378878445 ( Sakshi Sinha ) High Profile Call Girls...Ambala Escorts Service ☎️ 6378878445 ( Sakshi Sinha ) High Profile Call Girls...
Ambala Escorts Service ☎️ 6378878445 ( Sakshi Sinha ) High Profile Call Girls...
 
young call girls in Mahavir Nagar 🔝 9953056974 🔝 Delhi escort Service
young call girls in Mahavir Nagar 🔝 9953056974 🔝 Delhi escort Serviceyoung call girls in Mahavir Nagar 🔝 9953056974 🔝 Delhi escort Service
young call girls in Mahavir Nagar 🔝 9953056974 🔝 Delhi escort Service
 
slideshare Call girls Noida Escorts 9999965857 henakhan
slideshare Call girls Noida Escorts 9999965857 henakhanslideshare Call girls Noida Escorts 9999965857 henakhan
slideshare Call girls Noida Escorts 9999965857 henakhan
 
(INDIRA) Call Girl Kashmir Call Now 8617697112 Kashmir Escorts 24x7
(INDIRA) Call Girl Kashmir Call Now 8617697112 Kashmir Escorts 24x7(INDIRA) Call Girl Kashmir Call Now 8617697112 Kashmir Escorts 24x7
(INDIRA) Call Girl Kashmir Call Now 8617697112 Kashmir Escorts 24x7
 
Call Girls 🫤 East Of Kailash ➡️ 9999965857 ➡️ Delhi 🫦 Russian Escorts FULL ...
Call Girls 🫤 East Of Kailash ➡️ 9999965857  ➡️ Delhi 🫦  Russian Escorts FULL ...Call Girls 🫤 East Of Kailash ➡️ 9999965857  ➡️ Delhi 🫦  Russian Escorts FULL ...
Call Girls 🫤 East Of Kailash ➡️ 9999965857 ➡️ Delhi 🫦 Russian Escorts FULL ...
 
Vip Call Girls Vasant Kunj ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Vip Call Girls Vasant Kunj ➡️ Delhi ➡️ 9999965857 No Advance 24HRS LiveVip Call Girls Vasant Kunj ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Vip Call Girls Vasant Kunj ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
 
B2 Interpret the brief.docxccccccccccccccc
B2 Interpret the brief.docxcccccccccccccccB2 Interpret the brief.docxccccccccccccccc
B2 Interpret the brief.docxccccccccccccccc
 
Enjoy Night⚡Call Girls Udyog Vihar Gurgaon >༒8448380779 Escort Service
Enjoy Night⚡Call Girls Udyog Vihar Gurgaon >༒8448380779 Escort ServiceEnjoy Night⚡Call Girls Udyog Vihar Gurgaon >༒8448380779 Escort Service
Enjoy Night⚡Call Girls Udyog Vihar Gurgaon >༒8448380779 Escort Service
 
Nicola Mining Inc. Corporate Presentation May 2024
Nicola Mining Inc. Corporate Presentation May 2024Nicola Mining Inc. Corporate Presentation May 2024
Nicola Mining Inc. Corporate Presentation May 2024
 

Hemas Holdings PLC investor presentation 2015/16

  • 2. Contents 2 1 Hemas Business : Revenue and Profitability by Sector 2 History and Milestones 3 Consolidated Group Performance for FY 2015/16 4 Consumer 5 Healthcare 6 Transportation 7 Leisure 8 Sustainability 9 Vision 2020
  • 3. Hemas is a Wellness, Leisure and Mobility Business with LKR 38 billion in revenues 3 Revenue Segmental Revenue and Operating Profits, FY 2015/16 Operating Profit (Rs. Mn) FY 2015/16 Consumer 1,768 Healthcare 1,780 Leisure 255 Transportation 499 Other (342) Total 3,960 Consumer 38% Healthcare 42% Leisure 9% Transportation 5% Other 6% -500 0 500 1000 1500 2000 Consumer Healthcare Leisure Transportation Other OperatingProfitinLKRMillions
  • 4. History and Milestones 4 201420132011 Entry into Bangladesh 2007 Entered the Hospital business via Acquisition 20031970s Diversified into travel & tourism 1962 Entered the Consumer business 1948 Founded Hemas Drugs Ltd. Acquired J.L Morison Son & Jones (Ceylon) PLC Exited non-core business Hemas Holdings Listed on CSE
  • 5. Performance Indicator (Rs. Mn) FY 2015/16 FY 2014/15 % Change Group Revenue 37,978 32,497 16.9% Operating Profit 3,961 3,371 17.5% Profit After Tax 2.926 2,196 33.2% Group Earnings 2.653 1,927 37.7% Performance Indicator FY 2015/16 FY 2014/15 % Change ROE 14.1% 12.9% ROCE 16.8% 14.7% EPS 4.63 3.74 23.9% Net Assets per Share 38.41 30.39 26.3% Share Price (Mar 31) 80.60 73.70 9.3% Market Cap Rs. Mn (Mar 31) 46,147 37,977 21.5% Consolidated revenues for FY 2015/16 was LKR 38 Bn, up 16.9% over the previous year, with Group Earnings up 37.7% Growth coming primarily from strong performance in Consumer and Healthcare sectors. Hemas Holdings PLC, FY 2015/16 • HHL recorded solid performance for FY 2015/16 with consolidated Group of Rs. 38.0 Bn—a YoY growth of 16.9%. • Operating profit reached Rs. 4.0 Bn and Earnings Rs. 2.7Bn, a growth of 17.5% and 37.7% respectively. • Revenue growth was led by the strong performance of our Consumer and Healthcare sectors and additional interest income from the proceeds of the rights issue boosted Earnings. Segmental Earnings, FY 2015/16 5 -400 0 400 800 1,200 1,600 Consumer Healthcare Leisure Transportation Other Rs. Millions
  • 7. Hemas Consumer is Sri Lanka’s largest domestic Personal Care business, accounting for 38% of Group Revenues Hair CareOral CareBaby Care Feminine Hygiene Home CarePersonal Wash 7
  • 8. Hemas entered Bangladesh in 2011, and today we are the number two value-added hair oil brand with Kumarika • Kumarika hair oil has 16% market share in the value added oil segment, with 3-year revenue CAGR of 90%. • 115,000 urban and rural retail outlets reached; distribution reach grown 15% annually. • Operate own distribution, through a network of 140 distributors and over 100 sub-distributors. • 280 sales reps operating in 21 territories. • New product launched under “Kumarika” brand platform: two variants of a science + nature face wash. 0 400 800 1,200 1,600 2,000 2010/11 2011/12 2012/13 2013/14 2014/15 2015/16 Bangladesh Revenue in Rs. Million 2010/11–2015/16 8
  • 9. Market leader in personal care, strong iconic brands with international relevance Revenues up by 20% YoY, driven by robust volume growth in personal wash, feminine hygiene and home care. • Portfolio comprises personal care, personal wash and home care products. • Market leader in baby care, hair oil, and beauty soap. • Domestic distribution retail coverage of 80,000+. • Introduced new Gel variants of Clogard along with mouth wash product range and Velvet soap variants “Water Lily & Sea Minerals”, “Honey and Yoghurt.” • Fems, Clogard, Baby Cheramy and Diva brands posted double digit topline growth rates underpinning sector revenue growth. Sector Highlights • Consumer sector reported a total revenue of Rs. 14.3Bn, a 20.2% YoY growth. • Sector performance was driven by strong performance of Bangladesh operation and sales growth across all our major brands in the domestic market, with relatively weak commodity prices for key raw material inputs. Financial Highlights Consumer Revenue and Operating Profit FY 2011/12–2015/16 Consumer Revenue Share, FY 2015/16 9 '- 350 700 1,050 1,400 1,750 2,100 '- 3,000 6,000 9,000 12,000 15,000 18,000 2011/12 2012/13 2013/14 2014/15 2015/16 OperatingProfit-Rs.Million Revenue-Rs.Million Revenue Operating Profit Consumer 37.7%Rest of Group 62.3%
  • 11. Hemas is the largest healthcare company in Sri Lanka with interests in Pharmaceuticals, Hospitals and Diagnostics Pharmaceutical Distribution Rx & OTC Pharmaceutical Manufacturing Hospitals & Diagnostics Network 11
  • 12. In pharmaceutical distribution, Hemas represents the largest global multinational pharmaceutical manufacturers 650 Employees 35+ Principals 9 Therapeutic Categories 22% Market Share 3000+ Pharmacies 12 Hemas Pharmaceuticals
  • 13. OTC Own Brands • Lacto Calamine • Gripe Mixture • Baby Cough Syrup • Valmelix Cough Syrup JLM, acquired in 2013, is a market leading Rx manufacturer with leading OTC brands J.L. Morison Son & Jones 33% Earnings CAGR since acquisition Rs. 000’ FY 2014 FY 2015 FY 2016 Revenue 2,638,931 3,025,969 3,714,848 Operating Profit 258,189 324,173 460,516 Earnings 210,757 247,091 351,179 Financial Highlights 13 • Manufactures over sixty formulations of high quality pharmaceutical and OTC products. • Import and distribution of internationally renowned products via our island-wide distribution network. • JLM signed a five year buy-back agreement with the Government of Sri Lanka to provide essential medicines to the National Healthcare system. • JLM revenue and earnings for the year grew by 22.8% and 43.4% respectively supported by the growth of core segments, improved efficiency and capacity gains at plant, and the strength of a newly restructured distribution network.
  • 14. Hemas is the first hospital chain to take high quality private healthcare to rapidly growing Colombo suburbs • 3 multi-specialty, ACHSI accredited hospitals built on international standards in the North of Colombo, East of Colombo and in the Southern Province. • 3 additional laboratories opened this year; bring network up to 36 laboratories, serving over 500 physicians and addressing a patient population of 5 million. • Through our new corporate polyclinic model, we are locating in large working population environments, with a continued focus on bringing healthcare to the consumer. 14 Wattala 100 beds Thalawathugoda 60 beds Galle 50 beds
  • 15. Healthcare 42.5%Rest of Group 57.5% Deep experience across healthcare value chain with market leading positions in distribution and diagnostics Sector Highlights Financial Highlights • Healthcare segment of the Group achieved sales of Rs.16.1Bn, a growth of 16.0%. • 8% growth in Pharma distribution revenues indicates encouraging performance, during a period of significant regulatory change in the pharmaceutical industry. • Increased demand for private healthcare and health seeking behavior growing demand for diagnostics, all three hospitals recorded a revenue growth of 31.9% YoY. Healthcare Revenue and Operating Profit FY 2011/12–2015/16 Healthcare Revenue Share, FY 2015/16 15 '- 325 650 975 1,300 1,625 1,950 '- 3,000 6,000 9,000 12,000 15,000 18,000 2011/12 2012/13 2013/14 2014/15 2015/16 OperatingProfit-Rs.Million Revenue-Rs.Million Revenue Operating Profit • Hemas Hospitals opened its first wellness centre to 6,000 plus employees at Colombo’s premier IT park, Orion City. • Wattala and Southern Hospitals were re-accredited by the ACHSI and Hemas Hospital Thalawathugoda obtained its 1st accreditation during the year. • Pharmaceutical business grew Rx and OTC portfolio consistently, adding new principles. • JLM’s buyback agreement and continued focus on distribution efficiency contributed to the growth in sales
  • 17. Travel and Aviation OutboundMaritimeLogistics • Hemas offers complete passenger and cargo solutions in Airline Representation and travel related services • Hemas represents airlines Emirates, Malaysia Airline and Maldivian and other major airlines. • Largest GSA operator in passenger and cargo with a market share of 25% and 20%, respectively • Grew Emirates airlines from 1 flight per day to 7 flights per day • 5th in the travel market • Integrated portfolio of container haulage, container yard operations, warehousing, automotive logistics and transportation of project and over-dimensional cargo. • 6 acre container terminal. • Maritime sector acts as a shipping agent providing agency services for our feeder operator. • Far Shipping Lines (FSL) Singapore • Operates the largest feeder service to the Bay of Bengal • Exclusive agent for ‘HC line’ and NVOCC operator ‘Asian Tiger Shipping’ • Appointed General Agents for Evergreen, the fourth largest mainliner with revenues of US$ 4 Bn. • Award winning, IATA accredited travel agency. • Corporate travel service is a network partner of HRG which offers global travel services and hotel reservations. 17 Through our Mobility arm, we are securing new accounts and growing capacity in logistics, warehousing and haulage
  • 18. Transportation 4.7% Rest of Group 95.3% Our Mobility business had LKR 1.8 billion in revenues for FY 2015/16, a year-on-year growth of 17% Sector Highlights Financial Highlights • Transportation sector revenue of Rs.1.8 Bn reflects a YoY growth of 17.2%, stemming from strong performance of our domestic maritime and logistics business interests. • Logistics business grew through new projects, with our warehouses operating with full capacity and haulage business growing with the car carrier operation. • Aviation businesses continued to experience challenges due to lower yields of ticketing income. • Operating profits grew at a slower rate of 8.2% when compared to the revenue growth rate, due to limited growth reflected in aviation. Transportation Revenue and Operating Profit FY 2011/12–2015/16 Transportation Revenue Share, FY 2015/16 18 '- 85 170 255 340 425 510 595 '- 325 650 975 1,300 1,625 1,950 2011/12 2012/13 2013/14 2014/15 2015/16 OperatingProfit-Rs.Million Revenue-Rs.Million Revenue Operating Profit • Hemas Maritime appointed General Agents for Evergreen Marine Corporation Taiwan, one of the largest feeder carriers servicing the Port of Colombo. • Strategic investments in logistics verticals providing integrated end to end solutions • Good growth in Logistics 3PL business with increased volumes stemming from the container depot which functioned at its optimum level of efficiency.
  • 20. Our Leisure business comprises leading travel brands and an inbound leisure business • Serendib Leisure Group of Hotels which, includes four award winning properties with a total inventory of 550 rooms. • The partnership with Minor Hotel Group (MHG) has enabled Serendib Leisure to be the only Sri Lankan hotel chain to manage an international brand, “AVANI”. Coming Soon 20
  • 21. Leisure 9.0% Rest of Group 91.0% We are investing in Sri Lanka’s tourism boom with a selection of new builds, targeting the upper star class segment of the market YTD revenues of LKR 3.4Bn, with 13.0% increase year on year. • Owner and Manager of ffive properties with a combined room inventory of 563. • Strategic partnership with Minor Hotel Group, a leading Asian hotel chain • During December 2016, we opened our newest hotel property, Anantara Peace Haven Tangalle Resort, this property will establish a new benchmark for luxury travellers to Sri Lanka seeking authentic cultural experiences. • The hotels group revenue grew by 12.2% owing to the strong performance of AVANI Bentota and Hotel Sigiriya • Diethelm Travels recorded a 21% growth in the inbound volume which resulted a 14% growth in the topline. Sector Highlights Financial Highlights • Leisure segment recorded a total revenue of Rs. 3.4Bn for FY 2015/16, registering a 13.0% YoY increase. • The increase was primarily driven by a good overall occupancy rate of 79%. • The first few months of the new hotel Anantara Tangalle has been encouraging. Leisure Revenue and Operating Profit FY 2011/12–2015/16 Leisure Revenue Share, FY 2015/16 21 '- 65 130 195 260 325 390 455 520 585 '- 550 1,100 1,650 2,200 2,750 3,300 3,850 2011/12 2012/13 2013/14 2014/15 2015/16 OperatingProfit-Rs.Million Revenue-Rs.Million Revenue Operating Profit
  • 23. Enriching lives through the spirit of Abhimana • Abhimana’ is our ethos of sustainability that describes our vision of a sustainable and co- operative society, of people living and working together • Inline with this, we have released our Sustainability Report providing insight into the Group’s sustainability philosophy and initiatives in line with the Global Reporting Initiative G4 guidelines (GRI- G4) : http://www.hemas.com/reports • Today, our strategic path is governed not only by how well we develop growing commercial opportunities but also by listening to and responding to the communities of which we are a part. 23
  • 24. Piyawara • The Hemas ‘Piyawara’ project focuses on early childhood care and development, penetrating the segment by facilitating preschool education for children aged 3 to 5 years, from marginalised communities. • With the mission “to nurture young children with good care in order to provide a solid foundation of a life long journey” 24
  • 25. Vision 2020 - To be the best at enriching lives • Delighting South Asian consumers with our high quality innovative personal care solutions • Providing excellent healthcare outcomes for all Sri Lankans • Outstanding leisure experiences to the emerging traveler • Driving exceptional mobility solutions for the travel and logistics needs of the nation • While at all times operating true to Hemas Values and our ethos of Abhimana 25 2020 Vision
  • 26. Thank You CONFIDENTIALITY AGREEMENT: Any confidential information discussed in this presentation shall be used by the receiving party exclusively for the purposes of fulfilling the receiving party’s obligation and for no other purpose except with the consent of the disclosing party. Hemas Investor Relations: Telephone: +94 11 4 731 731 (Ext. 1278) Email: ir@hemas.com Web: http://www.hemas.com Hemas Holdings PLC Hemas House, 75, Braybrooke Place, Colombo 2, Sri Lanka 26